N
Nilavoli
About Nilavoli
Data last updated:
Nilavoli is a Director at Prosilio Pharmaceuticals Private Limited (since 2020). The companies operate in Pharma and Chemicals. Prosilio Pharmaceuticals Private Limited reported revenue of ₹3.08 Cr (FY 2024). Earlier, Nilavoli was a Director at Nanoceut Therapeutics Private Limited (2012–2014).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 27 Jul 2020 | 2018 | ₹3.08 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Apr 2012 | 2010 | ₹14.24 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Nilavoli
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mukeshmani Dhatchayani | 08250784 | Prosilio Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nilavoli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nilavoli
Nilavoli currently holds 1 directorship: Prosilio Pharmaceuticals Private Limited (Director, since 27 Jul 2020, revenue ₹3.08 Cr (FY 2024)).
Nilavoli was first appointed on 30 Apr 2012 as Director at Nanoceut Therapeutics Private Limited. The most recent appointment on record is 27 Jul 2020 at Prosilio Pharmaceuticals Private Limited.
Nilavoli held 1 earlier board appointment: Nanoceut Therapeutics Private Limited (Director, 30 Apr 2012 to 30 Jun 2014).
The current boards of Nilavoli's companies include Mukeshmani Dhatchayani (Prosilio Pharmaceuticals Private Limited).